Excessive daytime sleepiness Market Research Report Information By Diseases (Obstructive Sleep Apnea (OSA), Narcolepsy), By Treatment (Devices, Therapeutic Drugs (Stimulants, Anti-Depressants, Amphetamine salts, Sodium oxybate)) By Distribution channels (Hospitals & Sleep Laboratories, Home Care Settings), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Excessive Daytime Sleepiness Market Size was valued at USD 5.2 Billion in 2022. The excessive daytime sleepiness market industry is projected to grow from USD 5.57 Billion in 2023 to USD 9.72 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.20% during the forecast period (2023 – 2032).

Market Synopsis

Involuntary or unsuitable sleep causes excessive daytime sleepiness, defined as trouble in remaining awake and focused during the main hours of the day when one should be fully alert. Severe daytime sleepiness is connected with metabolic, cardiovascular, neurological and mental illnesses, also intentional acts indicating insufficient sleep and sleep debt that can end in disability or even death. The social and economic implications of this condition make it a major public health issue.

Sleep helps store memory, rejuvenate immune system among other key functions. Poor quality sleep may produce various symptoms not related to sleeping as such.

Polysomnograms (PSGs), Multiple Sleep Latency Tests (MSLTs) and Maintenance of Wakefulness Tests (MWTs) are conducted by university-based Sleep Labs which although more laborious than the ESS are useful for evaluating daytime alertness and fatigue.

Get Free Sample PDF Brochure @

https://www.marketresearchfuture.com/sample_request/20304

Market USP Covered:

Market Drivers:

EDS is rising all over the world, attributed to such reasons as sleep problems, lifestyle changes and stress resulting from jobs. Obstructive sleep apnea syndrome (EDS) is a complex disorder arising from sleep disorders like narcolepsy, obstructive sleep apnea, and shift work disorder that calls for effective treatment interventions.

Some of the diagnostic approaches that can be used to assess how severe EDS is as well as its causes include sleep studies, neurocognitive tests and questionnaires. Various options are available to treat people with this condition such as behavioral adjustments and pharmaceutical therapies like stimulants and wake promoting medications.

Furthermore, the market for EDS presents new therapeutic methods including neuromodulation techniques or novel drugs targeting some neurotransmitter systems related to regulation of sleep.

The market summary on excessive daytime sleepiness (EDS), often accompanied by hypersomnia disorder, shows the need for successful therapies. In response to higher rates of diagnosis and awareness raised in the pharmaceutical industry, companies are increasing their funds into research efforts on innovative therapeutics. Many stakeholders have focused on improving the quality of life of patients through novel remedies for this rampant sleeping disease.

Market Restraints:

Some obstacles that the EDS market encounters, specifically in underserviced areas are misdiagnosing, ignorance and unavailability of specialized management. Other problems include the need for more information. Partnerships between healthcare providers, academic institutions and firms that manufacture drugs are currently being promoted to enhance outcomes for patients while addressing challenges.

Browse In-depth Market Research Report (128 Pages) on Excessive daytime sleepiness Market:

https://www.marketresearchfuture.com/reports/excessive-daytime-sleepiness-market-20304

Market Segmentation

The excessive Daytime Sleepiness market segmentation, based on Diseases, includes Obstructive Sleep Apnea (OSA), Narcolepsy.

The excessive Daytime Sleepiness market segmentation, based on Treatment, includes Devices and therapeutic Drugs (Stimulants, Anti-depressants, Amphetamine salts, Sodium oxybate). 

The excessive Daytime Sleepiness market segmentation, based on Distribution channels, includes Hospitals & Sleep Laboratories and Home Care Settings. 

Market Competitive Landscape:

• Teva Pharmaceutical Industries Ltd.
• GE Healthcare
• Jazz Pharmaceuticals
• Compumedics
• Fisher & Paykel Healthcare
• BIOPROJET
• BMC Medical Co. Ltd.
• Avadel Pharmaceuticals plc
• Cadwell Laboratories Inc. Ltd
• GlaxoSmithKline plc
• Braebon Medical Corporation
• Pfizer

Regional Insights

A key geographic market, North America, will remain dominant throughout the review period, on account of the rising awareness and proactive initiatives in North America concerning sleep health importance and the implications of untreated illnesses, hence pushing diagnoses and interventions higher. Additionally, more fitness centers and health clubs are being opened in this part of the world, thereby further raising the market.

Discover More Research Reports on Healthcare Industry by Market Research Future:

Operating Table Parts Market Research Report, By Product Type (General, Specialty Surgery Table), Procedure (Anesthesia, Orthopedic, Neurology, Urology), Accessory (Standard Accessory), End-Users (Hospital, Clinics) – Global Forecast Till 2032

Blood Testing Market Research Report Information By Test Type (Complete Blood Count, Blood Chemistry Tests, and Enzyme Tests), By Disease (Anemia, Infection, and Leukemia), By Method (Manual and Automated), By End-User (Hospitals, and Diagnostic Center), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Acute Sinusitis Market Research Report Information By Treatment (Saline Nasal Spray, Nasal Corticosteroids, Decongestants, OTC Pain Relievers, Allergy Shots and Antibiotics), By End-Users (Hospitals & Clinics and Research Centers), By Diagnosis (Nasal Endoscopy, Imaging Test, Laboratory Test and Allergy Testing), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Cervical Cancer Treatment Market Research Report: Information By Type (Squamous Cell Carcinomas, Adenocarcinomas, and Adenosquamous Carcinomas), By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), By End-User (Cancer Care Centers, Pharmacies, And Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

Tags: Excessive daytime sleepiness Market, Excessive daytime sleepiness Market Analysis, Excessive daytime sleepiness Market Share, Excessive daytime sleepiness Market Size, Excessive daytime sleepiness Market Trends